Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
about
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposesCurrent Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine ModelsVisceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteasesUse of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis.Probiotic engineering: towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens.Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces.Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitisOral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in miceA review on Lactococcus lactis: from food to factory.Protease-activated receptors and their biological role - focused on skin inflammation.Unconjugated bilirubin ameliorates the inflammation and digestive protease increase in TNBS-induced colitis.Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option.Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases.CXCR4(+)-targeted protein nanoparticles produced in the food-grade bacterium Lactococcus lactis.Ectopic Expression of Innate Immune Protein, Lipocalin-2, in Lactococcus lactis Protects Against Gut and Environmental Stressors.Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.Synthetic Biology and the Gut Microbiome.Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.
P2860
Q26786083-0F3FA833-5881-4BA5-869A-BFAE80FA433DQ28083627-8CE51875-F459-49CA-903D-DB6636A7ED63Q28818844-CC399342-40D7-42F0-BFAD-CDD16BA5243BQ33650357-CB6B84A5-E0CF-438D-82F9-C31FB963B1F7Q33651733-8E1D89B0-D262-4397-8D52-38FD32F0D98EQ33766675-24CCA11A-3203-4ADE-9D26-EF29A3EE83B1Q35801931-96E14292-6A8C-425C-93A4-42489EBD3FACQ36020625-787DCE79-31C0-42C9-9F83-CF408B0D013EQ36036478-99745C84-3012-48E4-A15D-863DE30C2737Q36317250-C74D8AD6-296D-4318-A6A7-7938199A9C32Q37736878-CCE3C6BF-BB27-441E-9FB9-4D011B49D9D3Q38680840-8173559A-2E82-475A-A4D6-763188ED8944Q38705943-C21F4316-ED9B-4882-BC95-7C6C4D5911C1Q38827869-2D3D2B7C-5773-4DA8-AA23-10679C4F461CQ39127400-CE17A8D8-2B32-448E-AF6F-A85A3B32A8F8Q39485838-605E457F-B056-4787-8B72-F55E10BA6825Q40236848-7BD7B049-77E5-4877-B70C-DDEE4FECF03DQ47588260-442FC2FD-6DEE-4228-AF19-FFD1CA570417Q47915556-8B0CABAB-76DF-4A62-8262-F9D9C8CAC3D7Q49444745-E15F73A5-3DDB-4D40-AC8A-1BCABA96D54C
P2860
Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serine protease inhibitors pro ...... red by recombinant lactococci.
@en
type
label
Serine protease inhibitors pro ...... red by recombinant lactococci.
@en
prefLabel
Serine protease inhibitors pro ...... red by recombinant lactococci.
@en
P2093
P2860
P50
P1476
Serine protease inhibitors pro ...... red by recombinant lactococci.
@en
P2093
Camille Aubry
Céline Deraison
Laurence Rous-Martin
Luis G Bermúdez-Humarán
Pascale Kharrat
Philippe Langella
P2860
P2888
P356
10.1186/S12934-015-0198-4
P577
2015-02-26T00:00:00Z
P5875
P6179
1027994056